M&A Deal Summary |
|
|---|---|
| Date | 2010-01-06 |
| Target | InSound Medical |
| Sector | Medical Products |
| Buyer(s) | Sonova Holding |
| Sellers(s) |
EW Healthcare Partners
SightLine Partners |
| Deal Type | Add-on Acquisition |
| Deal Value | 75M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 1947 |
| Sector | Healthcare Services |
| Employees | 17,073 |
| Revenue | 3.4B CHF (2022) |
Sonova Holding is the world's leading provider of hearing systems, announced today that it has successfully completed its acquisition of InSound Medical Inc., Newark, USA. InSound Medical developed the first extended wear hearing system which is placed deep in the ear canal and totally invisible from the outside, and markets it under the Lyric brand. The total transaction price is made up of two components: an up-front cash consideration of USD 75 million and earn-out payments which depend on the company's financial success going forward. The regulatory approvals needed for the transaction have been obtained. Sonova Holding was founded in 1947 and is based in Staefa, Switzerland.
| DEAL STATS | # |
|---|---|
| Overall | 3 of 7 |
| Sector (Medical Products) | 2 of 4 |
| Type (Add-on Acquisition) | 2 of 5 |
| State (California) | 2 of 2 |
| Country (United States) | 2 of 3 |
| Year (2010) | 1 of 1 |
| Size (of disclosed) | 5 of 5 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-11-10 |
Advanced Bionics
Valencia, California, United States Advanced Bionics develops the most advanced cochlear implant systems in the world. With operations in over 50 countries and a track record for developing high-performing, state-of-the-art products, AB’s talented, group of technologists and professionals are driven to succeed, work with integrity, and stay firmly committed to quality while delivering unmatched customer service. |
Buy | $489M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-04-16 |
Hansaton Akustik
Hamburg, Germany Hansaton Akustik GmbH is a manufacturer of hearing systems for people with hearing problems. |
Buy | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 1985 |
| PE ASSETS | 3.0B USD |
| Size | Large |
| Type | Sector Focused |
Essex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.
| DEAL STATS | # |
|---|---|
| Overall | 17 of 52 |
| Sector (Medical Products) | 8 of 23 |
| Type (Add-on Acquisition) | 10 of 34 |
| State (California) | 7 of 16 |
| Country (United States) | 15 of 45 |
| Year (2010) | 2 of 7 |
| Size (of disclosed) | 21 of 22 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-01-04 |
BioForm Medical
San Mateo, California, United States Bioform Medical is a medical device company introducing a family of proprietary, injectable implant products used in minimally invasive soft tissue augmentation procedures. The lead product, Radiesse, will be used for aesthetic/cosmetic indications. |
Sell | $253M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-04-06 |
Ception Therapeutics
Malvern, Pennsylvania, United States Ception Therapeutics, Inc. is a emerging biopharmaceutical company which develops novel products to address unmet medical needs. |
Sell | - |
| Category | Growth Capital Firm |
|---|---|
| Founded | 2004 |
| Size | Small |
| Type | Sector Focused |
SightLine Partners is a private investment firm that targets early to late stage investments in growing healthcare and medical technology companies. Depending on the maturity of the company, Sightline will invest between $2 and $8 million per transaction. SightLine prefers US based opportunities. SightLine Partners LLC was formed in 2004 and is based in Minneapolis, Minnesota.
| DEAL STATS | # |
|---|---|
| Overall | 12 of 16 |
| Sector (Medical Products) | 12 of 15 |
| Type (Add-on Acquisition) | 10 of 12 |
| State (California) | 6 of 7 |
| Country (United States) | 12 of 16 |
| Year (2010) | 1 of 3 |
| Size (of disclosed) | 6 of 7 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2009-06-12 |
Anulex Technologies
Minnetonka, Minnesota, United States Anulex Technologies is a privately held company dedicated to the development and commercialization of unique and proprietary soft tissue repair products with primary interests in treatments for the soft tissues of the spine. Back pain afflicts four out of every five individuals at some point during their life, and it is a major cause of disability. Anulex Technologies is based in Minnetonka, Minnesota. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2010-09-20 |
Asthmatx
Sunnyvale, California, United States Asthmatx, Inc. is a privately-held medical device company focused on helping patients breathe easier. |
Sell | $194M |
